The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application for the mark TRI-VYLIBRA AX. The application, filed on November 12, 2025, under application number 99492415, is specifically for use in connection with oral contraceptives.

This filing signifies the applicant's intent to use the mark in commerce for pharmaceutical products. While this is an intent-to-use application and not a final registration, it indicates a planned product launch in the oral contraceptive market. Companies operating in this space should be aware of new brand entries and potential trademark conflicts.